Literature DB >> 12890486

Localization of Tie2 and phospholipase D in endothelial caveolae is involved in angiopoietin-1-induced MEK/ERK phosphorylation and migration in endothelial cells.

Mi-Jeong Yoon1, Chung-Hyun Cho, Chang Sup Lee, Il-Ho Jang, Sung Ho Ryu, Gou Young Koh.   

Abstract

Angiopoietin-1 (Ang1) and its receptor, Tie2, play critical roles in blood vessel formation. Ang1 triggers a variety of signaling events in endothelial cells leading to vasculogenic and angiogenic processes. However, the underlying mechanism for Ang1/Tie2 signaling is not fully understood. Here, we show that Tie2 and phospholipase D (PLD) are localized in the caveolae, specialized subdomains of the endothelial cell plasma membrane enriched with signaling molecules. Interestingly, Ang1 increased PLD activities in a dose- and time-dependent manner. Ang1-induced MEK/ERK activation was abrogated when PLD was inhibited, suggesting that PLD mediates Ang1-induced MEK/ERK activation. Moreover, PLD inhibitor, 1-butanol, inhibited Ang1-induced endothelial cell migration. Our results indicate that: (1) caveolae may be the platform for Tie2/PLD association in endothelial cells; (2) PLD is a new mediator of Ang1/Tie2-induced signaling pathway, and it participates in MAPK activation and endothelial cell migration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890486     DOI: 10.1016/s0006-291x(03)01341-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Common and specific effects of TIE2 mutations causing venous malformations.

Authors:  Marjut Nätynki; Jaakko Kangas; Ilkka Miinalainen; Raija Sormunen; Riikka Pietilä; Julie Soblet; Laurence M Boon; Miikka Vikkula; Nisha Limaye; Lauri Eklund
Journal:  Hum Mol Genet       Date:  2015-08-28       Impact factor: 6.150

2.  Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.

Authors:  Melanie Uebelhoer; Marjut Nätynki; Jaakko Kangas; Antonella Mendola; Ha-Long Nguyen; Julie Soblet; Catherine Godfraind; Laurence M Boon; Lauri Eklund; Nisha Limaye; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2013-04-30       Impact factor: 6.150

3.  Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis.

Authors:  Brooke Harmon; Benjamin R Schudel; Dianna Maar; Carol Kozina; Tetsuro Ikegami; Chien-Te Kent Tseng; Oscar A Negrete
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

4.  Increased myocardial expression of angiopoietin-2 in patients undergoing urgent surgical revascularization for acute coronary syndromes.

Authors:  Neil P Fam; Sara Arab; Filio Billia; Robin Han; Gerald Proteau; David Latter; Lee Errett; Daniel Bonneau; Rosemary Dunne; Peter P Liu; Duncan J Stewart
Journal:  Can J Cardiol       Date:  2010 Aug-Sep       Impact factor: 5.223

5.  Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.

Authors:  Christudas Morais; Quteba Ebrahem; Bela Anand-Apte; Marie-Odile Parat
Journal:  Am J Pathol       Date:  2012-02-07       Impact factor: 4.307

6.  Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.

Authors:  Jeff H Tsai; William M F Lee
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

7.  Molecular Changes Associated with the Protective Effects of Angiopoietin-1 During Blood-Brain Barrier Breakdown Post-Injury.

Authors:  Sukriti Nag; Janet L Manias; Anish Kapadia; Duncan J Stewart
Journal:  Mol Neurobiol       Date:  2016-06-22       Impact factor: 5.590

8.  Basal and angiopoietin-1-mediated endothelial permeability is regulated by sphingosine kinase-1.

Authors:  Xiaochun Li; Milena Stankovic; Claudine S Bonder; Christopher N Hahn; Michelle Parsons; Stuart M Pitson; Pu Xia; Richard L Proia; Mathew A Vadas; Jennifer R Gamble
Journal:  Blood       Date:  2008-01-16       Impact factor: 22.113

Review 9.  Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?

Authors:  Matijs van Meurs; Philipp Kümpers; Jack J M Ligtenberg; John H J M Meertens; Grietje Molema; Jan G Zijlstra
Journal:  Crit Care       Date:  2009-03-09       Impact factor: 9.097

10.  Somatic activating mutations in Pik3ca cause sporadic venous malformations in mice and humans.

Authors:  Sandra D Castillo; Elena Tzouanacou; May Zaw-Thin; Inma M Berenjeno; Victoria E R Parker; Iñigo Chivite; Maria Milà-Guasch; Wayne Pearce; Isabelle Solomon; Ana Angulo-Urarte; Ana M Figueiredo; Robert E Dewhurst; Rachel G Knox; Graeme R Clark; Cheryl L Scudamore; Adam Badar; Tammy L Kalber; Julie Foster; Daniel J Stuckey; Anna L David; Wayne A Phillips; Mark F Lythgoe; Valerie Wilson; Robert K Semple; Neil J Sebire; Veronica A Kinsler; Mariona Graupera; Bart Vanhaesebroeck
Journal:  Sci Transl Med       Date:  2016-03-30       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.